A detailed history of Bank Of Nova Scotia transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Of Nova Scotia holds 7,784 shares of NVO stock, worth $840,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,784
Holding current value
$840,749
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $926,840 - $1.13 Million
7,784 New
7,784 $926,000
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $97,523 - $117,154
1,111 Added 38.63%
3,987 $412,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $261,543 - $573,877
2,876 New
2,876 $261,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.